Nebivolol tablets
Form: Tablets
Strength: 2.5 mg, 5 mg, and 10 mg
Reference Brands: Bystolic(US & EU)
Category: Hypertension
Nebivolol tablets, marketed as Bystolic, are approved in the US by the FDA and in the EU via EMA for hypertension and heart failure. Regulatory approval requires detailed dossiers including clinical efficacy, safety data, manufacturing standards, and pharmacovigilance plans. The FDA reviews comprehensive clinical and quality data for timely approval, while the EMA ensures regional safety and manufacturing compliance. For guidance on dossier preparation, regulatory pathways, and market access, visit PharmaTradz. Proper regional adherence supports rapid approval, safe use, and global availability of nebivolol tablets, helping patients worldwide manage cardiovascular health effectively and sustainably.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Related Products
Antithymocyte Globulin (ATG) powder for injection
Strength: 250mg/5ml
Form: Lyophilized powder
Reference Brands: Thymoglobulin(US & EU)
View Details Get Enquiry
Hydralazine tablets
Strength: 10 mg, 25 mg, 50 mg, 100 mg
Form: Tablets
Reference Brands: Apresoline(US & Eu)
View Details Get Enquiry
Methyldopa tablets
Strength: 250 mg, 500 mg, and 750 mg
Form: Tablets
Reference Brands: Aldomet(US)
View Details Get Enquiry
Clonidine Patch
Strength: 0.1 mg/24 hours, 0.2 mg/24 hours, 0.3 mg/24 hours
Form: transdermal patch
Reference Brands: Catapres(US)
View Details Get Enquiry